Dexmedetomidine and Magnesium Sulfate in the Reduction Cognitive Dysfunction in Geriatrics

PHASE1RecruitingINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

November 21, 2024

Primary Completion Date

April 30, 2025

Study Completion Date

May 15, 2025

Conditions
Mental Disorder
Interventions
DRUG

dexmedetomidine

20 mg/kg as a loading dose over 10 minutes before induction then a maintenance dose of 5 mg/kg/hour, which will also be discontinued at the skin closure.

Trial Locations (1)

Unknown

RECRUITING

Dexmedetomidine, Al Fayyum

All Listed Sponsors
lead

Fayoum University

OTHER